Ann: Update on expected revenue for H1, page-45

Veecat - you are dead on mate as nothing is propping this share price up right now with no revenue and a big cash burn on expenses. This managing director, Judith Mitchell is in way over her head as referenced and evidenced by all on this chat board for over the past three years now. It all boils down to mis aligned partnerships, horrifically wrong market pricing calculations and a complete lack of experience in how to bring products to market in the states. Need I say more. This last announcement of revised downward earnings was just another example. I for one believe in the x bio platform but until this worthless management team and board are replaced then I see no value in owning the shares - especially when they stuff themselves with more stock options then should be legally allowed and as they cash out at a high rate as the bloody things become un escrowed all the time. As always, do your own due diligence. Cheers.